The peptide field, explained honestly.
Clear, cited, hype-free explainers on how peptides work, what the research supports, and how to think about the trade-offs — written to inform decisions, not sell them.
Reading a certificate of analysis: peptide purity explained
A COA is only meaningful if you know what its lines mean. Here's how to read identity, purity, and endotoxin — and why they matter.
Why medical supervision matters for peptide therapy
The single biggest difference between a safe peptide protocol and a risky one isn't the compound — it's whether a licensed provider is involved.
NAD+, MOTS-c and the longevity conversation
Cellular energy, mitochondria, and the peptides at the center of the aging discussion — separating mechanism from hype.
Peptides for recovery: BPC-157, TB-500 and regenerative blends
The regenerative peptides athletes and clinicians talk about most — what the research explores, and why combinations are common.
GLP-1 peptides compared: Semaglutide, Tirzepatide & Retatrutide
Three generations of incretin therapy — single, dual, and triple receptor agonists. How they differ, what the trials showed, and how to think about the trade-offs.
What are peptides? A clinical primer
Short chains of amino acids that act as biological signals — and why they're one of the most-watched frontiers in metabolic and regenerative medicine.
The peptide field, in your inbox.
Evidence-led updates on protocols, new research, and formulary additions. No hype — unsubscribe anytime.